Other functions - preclinical in vitro and in vivo agent development assays
Ended Awarded Last action
- Contract number
- HHSN261201200020I
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 7 $3,994,317 obligated
Award facts
- Combined order value
- $3,994,279 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 40% used
- $9,900,000.00
- Maximum order
- $5,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is an Indefinite Delivery Contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of Oklahoma (OU). The contract vehicle is titled "Preclinical Agent Development Assays 2012-2016" and has a ceiling value of $9,900,000. Under this IDIQ contract, OU has been issued multiple delivery orders totaling over $4.8 million to conduct preclinical research and development services focused on cancer prevention. This includes testing the efficacy of agents like bexarotene, naproxen, aspirin, and omeprazole for the prevention of lung, pancreatic, and colorectal cancers using in vitro and in vivo models. The work is performed at OU's facilities in Oklahoma City. None of the task orders reviewed utilized small business set-asides. This contract supports NCI's mission of advancing cancer prevention and treatment through the preclinical development of novel drugs and therapies.
The University of Oklahoma, a public research university, has a demonstrated history of providing medical research, healthcare, and education services to various federal agencies as both a prime contractor and subcontractor. This includes delivering radiopharmaceuticals, animal housing, physician services, and research support to agencies like the VA, DoD, HHS, and DoJ. OU's experience and expertise in these areas likely contributed to its selection as the prime contractor for this NCI IDIQ focused on preclinical cancer research.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201200020I?
HHSN261201200020I was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN261201200020I worth?
Orders under HHSN261201200020I have obligated $3,994,317. Their combined current value, with exercised options, is $3,994,279. HHSN261201200020I's own ceiling is $9,900,000. A single order can be worth up to $5,000,000.
How many orders have been placed under contract HHSN261201200020I?
7 orders have been placed under HHSN261201200020I, the latest on September 12, 2014.
Who can order from contract HHSN261201200020I?
HHSN261201200020I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201200020I part of a contract vehicle?
Yes. HHSN261201200020I is part of Preclinical Agent Development Assays 2012-2016.
Was contract HHSN261201200020I competed?
The extent of competition for HHSN261201200020I was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV